UBS Group’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-23,000
Closed -$801K 10450
2022
Q2
$801K Buy
23,000
+2,800
+14% +$110K ﹤0.01% 3902
2022
Q1
$1.05M Buy
+20,200
New +$1.02M ﹤0.01% 4048

Other funds holding DOCS

UBS Group's DOCS Position: Q2 2026 in Review

UBS Group increased its Doximity (DOCS) stake by 39% in Q2 2026, buying an estimated $5.65M and bringing the position to 909,759 shares worth $18.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2749.

UBS Group first reported a position in DOCS in Q2 2021 and has held it in 21 quarters since. The position peaked at $63.1M in Q1 2025. 359 funds tracked by Wall St. Rank hold DOCS as of Q2 2026.

  • UBS Group held 909,759 shares of Doximity worth $18.9M as of Q2 2026.
  • UBS Group bought 255,497 Doximity shares in Q2 2026, an estimated $5.65M.
  • Doximity made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2749 holding.
  • UBS Group first reported a position in Doximity in Q2 2021 and has held it in 21 quarters since.
  • UBS Group's Doximity position peaked at $63.1M in Q1 2025.
  • 359 funds tracked by Wall St. Rank held Doximity as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.